Sensei Biotherapeutics, Inc. (SNSE)
26.02
+0.16
(+0.62%)
USD |
NASDAQ |
May 06, 16:00
26.26
+0.24
(+0.92%)
Pre-Market: 20:00
Sensei Biotherapeutics Cash from Investing (Quarterly) : 1.743M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0009M |
| Vir Biotechnology, Inc. | 86.65M |
| Acurx Pharmaceuticals, Inc. | 0.00 |
| Tango Therapeutics, Inc. | -135.72M |
| Xilio Therapeutics, Inc. | -0.095M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.586M |
| Cash from Financing (Quarterly) | -0.152M |
| Free Cash Flow | -22.40M |
| Free Cash Flow Per Share (Quarterly) | -2.843 |
| Free Cash Flow to Equity (Quarterly) | -3.048M |
| Free Cash Flow to Firm (Quarterly) | -3.58M |
| Free Cash Flow Yield | -11.88% |